|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 327.10 CHF | +0.77% |
|
-0.67% | -0.34% |
| Jun. 05 | Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial | RE |
| Jun. 05 | Zealand touts promising tolerability data for obesity drug in mid-stage study | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ROP Stock
- Consensus Roche Holding AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
